Skip to main content

May 2016, Vol 6, No 5

Researchers in Chicago have developed a financial toxicity grading system based on clinically meaningful changes in health-related quality of life. According to lead investigator Jonas A. de Souza, MD, Assistant Professor of Medicine, University of Chicago, at the 2016 Cancer Survivorship Symposium, the tool has been validated in 2 separate cohorts of patients with cancer, with plans for a larger, prospective study underway. Read More ›

Last month, I discussed the barriers to obtaining nutritional support for patients with cancer. This second article is focused on the return on investment to all stakeholders from ensuring nutritional support for patients with cancer. Read More ›

The following clinical trials represent a selection of key studies that are currently recruiting patients with brain cancer for inclusion in investigations of new therapies and new regimens of available therapies for patients with brain cancer. Read More ›

Healthcare providers in private practice often ask whether they should form a legal entity. You need to decide if you want to “incorporate,” and to determine which business entity is best for you based on your individual needs and goals. Read More ›


Page 2 of 2